Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD.

Diabetes Care. 2005 May;28(5):1092-100.

PMID:
15855572
2.

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.

Iltz JL, Baker DE, Setter SM, Keith Campbell R.

Clin Ther. 2006 May;28(5):652-65. Review.

PMID:
16861088
3.
4.

Exenatide: a review from pharmacology to clinical practice.

Gentilella R, Bianchi C, Rossi A, Rotella CM.

Diabetes Obes Metab. 2009 Jun;11(6):544-56. doi: 10.1111/j.1463-1326.2008.01018.x. Epub 2009 Apr 5. Review.

PMID:
19383034
5.

Exenatide efficacy and safety: a systematic review.

Norris SL, Lee N, Thakurta S, Chan BK.

Diabet Med. 2009 Sep;26(9):837-46. doi: 10.1111/j.1464-5491.2009.02790.x. Review.

PMID:
19719703
6.

Exenatide: from the Gila monster to the pharmacy.

Triplitt C, Chiquette E.

J Am Pharm Assoc (2003). 2006 Jan-Feb;46(1):44-52; quiz 53-5. Review.

PMID:
16529340
7.

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.

Schnabel CA, Wintle M, Kolterman O.

Vasc Health Risk Manag. 2006;2(1):69-77. Review.

8.

[Exenatide trials for the treatment of type 2 diabetes].

Fernández Landó L, Casellini CM.

Medicina (B Aires). 2009;69(4):447-57. Review. Spanish. Erratum in: Medicina (B Aires). 2010;70(2):193.

PMID:
19770100
9.

Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes.

Aroda VR, DeYoung MB.

Postgrad Med. 2011 Sep;123(5):228-38. doi: 10.3810/pgm.2011.09.2479. Review.

PMID:
21904106
10.

Evolution of exenatide as a diabetes therapeutic.

Bhavsar S, Mudaliar S, Cherrington A.

Curr Diabetes Rev. 2013 Mar 1;9(2):161-93. Review.

11.

Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus.

Ryan GJ, Moniri NH, Smiley DD.

Am J Health Syst Pharm. 2013 Jul 1;70(13):1123-31. doi: 10.2146/ajhp120168. Review.

PMID:
23784159
12.

Exenatide extended-release: a review of its use in type 2 diabetes mellitus.

Scott LJ.

Drugs. 2012 Aug 20;72(12):1679-707. doi: 10.2165/11209750-000000000-00000. Review.

PMID:
22867046
13.

Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus.

McCormack PL.

Drugs. 2014 Mar;74(3):325-51. doi: 10.1007/s40265-013-0172-6. Review.

PMID:
24435322
14.

Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus.

Tzefos M, Olin JL.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1294-300. doi: 10.1345/aph.1P047. Epub 2010 Jun 8. Review.

PMID:
20530705
15.

Is exenatide a useful addition to diabetes therapy?

Mikhail NE.

Endocr Pract. 2006 May-Jun;12(3):307-14. Review.

PMID:
16772206
16.

Once weekly exenatide: efficacy, tolerability and place in therapy.

Wysham C, Grimm M, Chen S.

Diabetes Obes Metab. 2013 Oct;15(10):871-81. doi: 10.1111/dom.12084. Epub 2013 Mar 24. Review.

PMID:
23425609
17.

[Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].

Hermann LS, Melander A.

Lakartidningen. 1999 Dec 15;96(50):5616-9. Review. Swedish.

PMID:
10643226
18.

[Clinical application of exenatide in Japanese patients with type 2 diabetes mellitus].

Toyonaga T, Araki E.

Nihon Rinsho. 2011 May;69(5):890-4. Review. Japanese.

PMID:
21595277
19.

Exenatide: AC 2993, AC002993, AC2993A, exendin 4, LY2148568.

[No authors listed]

Drugs R D. 2004;5(1):35-40. Review.

PMID:
14725490
20.

The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review.

Best JH, Lavillotti K, DeYoung MB, Garrison LP.

Diabetes Obes Metab. 2012 May;14(5):387-98. doi: 10.1111/j.1463-1326.2011.01533.x. Epub 2011 Dec 27. Review.

PMID:
22074017
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk